Company profile
UK company 11666403, incorporated on 8 November 2018.
3D Bio-Tissues | Powered by BSF Enterprise
We're a Bio-Tech startup, spun-out from Newcastle University in 2019. Our ambition is to produce bio-equivalent tissues for clinical and cellular agriculture. We apply novel bio-inspired manufacturing processes to generate complex structure.
Company number 11666403
Financial period: 1 Oct 2023 to 30 Sep 2024
Reference milestones and recent Companies House filing stream events.
GUARANTEE2 | Transaction MzUzODkzMDgyMmFkaXF6a2N4 | Paper/PDF filed
Published 19 Aug 2026 22:51
GUARANTEE2 | Transaction MzUzODkzMDgyNWFkaXF6a2N4 | Paper/PDF filed
Published 15 Aug 2026 08:45
CS01 | Transaction MzUzODAzNjgwOWFkaXF6a2N4
Published 11 Aug 2026 14:41
PARENT_ACC | Transaction MzUzMzU3Mzc2N2FkaXF6a2N4 | Paper/PDF filed
Published 18 Jul 2026 07:06
AGREEMENT2 | Transaction MzUzMzU3MzY2MmFkaXF6a2N4 | Paper/PDF filed
Published 18 Jul 2026 06:59
Company registered at Companies House
3D Bio-Tissues operates a biotechnology firm that develops 3D-printed human tissues such as the cornea.
The Company "3D Bio-Tissues" (3DBT) has identified a significant and unique commercial opportunity in the rapidly developing 3D bio-printing market. We will offer superior, transplantable corneal replicates for the treatment of corneal stromal disorders. These tissue engineered replicates will uniquely conform to the hosts' needs in terms of shape and thickness, providing adequate cells and materials for the restoration of the patients' sight.
Will employ technology developed by Prof Connon on 3D printing the cornea Now listed on LSE under BSF Enterprise PLC 2023 First to create whole cut pork fillet using scaffold free technology i.e. 100% meat
Will employ technology developed by Prof Connon on 3D printing the cornea
1 Jan 2024 to 31 Dec 2025
3D Bio-Tissues (3DBT) has developed a range of proprietary ingredients for cell culture media that greatly promotes the growth and tissue formation capabilities of various cell types, including those necessary for cultivated meat production. The supplementation of chemically-defined, serum-free culture media with these ingredients helps reduce the need fo...
1 Jan 2023 to 31 Dec 2023
3D Bio-Tissues (3DBT) has developed a range of proprietary ingredients for cell culture media that greatly promotes the growth and tissue formation capabilities of various cell types, including those necessary for cultivated meat production. The supplementation of chemically-defined, serum-free culture media with these ingredients helps reduce the need fo...
1 Oct 2020 to 31 Mar 2022
3D Bio-Tissues Ltd (3DBT) is a Newcastle University spin-out company that is translating recent developments in cell biology and tissue engineering into medical and food-related products. The company has developed a process that produces highly organised collagenous tissue. The similarity in structure between these engineered tissues and their natural cou...
